{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:16:45Z","timestamp":1790446605475,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Melanoma cells use different migratory strategies to exit the primary tumor mass and invade surrounding and subsequently distant tissues. We reported previously that ADAR1 expression is downregulated in metastatic melanoma, thereby facilitating proliferation. Here we show that ADAR1 silencing enhances melanoma cell invasiveness and ITGB3 expression. The enhanced invasion is reversed when ITGB3 is blocked with antibodies. Re-expression of wild-type or catalytically inactive ADAR1 establishes this mechanism as independent of RNA editing. We demonstrate that ADAR1 controls ITGB3 expression both at the post-transcriptional and transcriptional levels, via miR-22 and PAX6 transcription factor, respectively. These are proven here as direct regulators of ITGB3 expression. miR-22 expression is controlled by ADAR1 via FOXD1 transcription factor. Clinical relevance is demonstrated in patient-paired progression tissue microarray using immunohistochemistry. The novel ADAR1-dependent and RNA-editing-independent regulation of invasion, mediated by ITGB3, strongly points to a central involvement of ADAR1 in cancer progression and metastasis.<\/jats:p>","DOI":"10.1038\/s41467-018-04600-2","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T14:19:47Z","timestamp":1527257987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["ADAR1-mediated regulation of melanoma invasion"],"prefix":"10.1038","volume":"9","author":[{"given":"Yael","family":"Nemlich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erez Nissim","family":"Baruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal Judith","family":"Besser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einav","family":"Shoshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menashe","family":"Bar-Eli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Anafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Barshack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Schachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona","family":"Ortenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Markel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"4600_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1600-0749.2007.00378.x","volume":"20","author":"C Gaggioli","year":"2007","unstructured":"Gaggioli, C. & Sahai, E. Melanoma invasion\u2014current knowledge and future directions. Pigment Cell Res. 20, 161\u2013172 (2007).","journal-title":"Pigment Cell Res."},{"key":"4600_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1600-0749.2005.00235.x","volume":"18","author":"NK Haass","year":"2005","unstructured":"Haass, N. K., Smalley, K. S. M., Li, L. & Herlyn, M. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 18, 150\u2013159 (2005).","journal-title":"Pigment Cell Res."},{"key":"4600_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/pcmr.12041","volume":"26","author":"JL Orgaz","year":"2013","unstructured":"Orgaz, J. L. & Sanz-Moreno, V. Emerging molecular targets in melanoma invasion and metastasis. Pigment. Cell Melanoma Res. 26, 39\u201357 (2013).","journal-title":"Pigment. Cell Melanoma Res."},{"key":"4600_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9\u201322 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"4600_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1755-148X.2010.00806.x","volume":"24","author":"P Pinon","year":"2011","unstructured":"Pinon, P. & Wehrle-Haller, B. Integrins: versatile receptors controlling melanocyte adhesion, migration and proliferation. Pigment. Cell Melanoma Res. 24, 282\u2013294 (2011).","journal-title":"Pigment. Cell Melanoma Res."},{"key":"4600_CR6","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood.V92.8.2777","volume":"92","author":"Y Jin","year":"1998","unstructured":"Jin, Y. et al. Human integrin \u03b23 gene expression: evidence for a megakaryocytic cell-specific cis-acting element. Blood 92, 2777\u20132790 (1998).","journal-title":"Blood"},{"key":"4600_CR7","doi-asserted-by":"publisher","first-page":"23791","DOI":"10.1074\/jbc.M800190200","volume":"283","author":"H Hayashi","year":"2008","unstructured":"Hayashi, H., Sano, H., Seo, S. & Kume, T. The Foxc2 transcription factor regulates angiogenesis via induction of integrin \u03b23 expression. J. Biol. Chem. 283, 23791\u201323800 (2008).","journal-title":"J. Biol. Chem."},{"key":"4600_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-577","volume":"14","author":"Y Chi","year":"2014","unstructured":"Chi, Y. et al. CDK11(p58) inhibits ER\u03b1-positive breast cancer invasion by targeting integrin \u03b23 via the repression of ER\u03b1 signaling. BMC Cancer 14, 577 (2014).","journal-title":"BMC Cancer"},{"key":"4600_CR9","doi-asserted-by":"publisher","first-page":"6698","DOI":"10.1038\/onc.2008.282","volume":"27","author":"DW Muller","year":"2008","unstructured":"Muller, D. W. & Bosserhoff, A. K. Integrin [beta]3 expression is regulated by let-7a miRNA in malignant melanoma. Oncogene 27, 6698\u20136706 (2008).","journal-title":"Oncogene"},{"key":"4600_CR10","first-page":"2689","volume":"8","author":"R Ni","year":"2015","unstructured":"Ni, R., Huang, Y. & Wang, J. miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer. OncoTargets Ther. 8, 2689\u20132697 (2015).","journal-title":"OncoTargets Ther."},{"key":"4600_CR11","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1007\/s11033-014-3110-0","volume":"41","author":"C Shang","year":"2014","unstructured":"Shang, C. et al. MiR-320a down-regulation mediates bladder carcinoma invasion by targeting ITGB3. Mol. Biol. Rep. 41, 2521\u20132527 (2014).","journal-title":"Mol. Biol. Rep."},{"key":"4600_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0344-y","volume":"14","author":"L Sun","year":"2015","unstructured":"Sun, L. et al. MiR-320a acts as a prognostic factor and inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3. Mol. Cancer 14, 96 (2015).","journal-title":"Mol. Cancer"},{"key":"4600_CR13","doi-asserted-by":"crossref","first-page":"43712","DOI":"10.18632\/oncotarget.6227","volume":"6","author":"SY Yang","year":"2015","unstructured":"Yang, S. Y. et al. miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47. Oncotarget 6, 43712\u201343730 (2015).","journal-title":"Oncotarget"},{"key":"4600_CR14","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1038\/onc.2010.167","volume":"29","author":"F Yu","year":"2010","unstructured":"Yu, F. et al. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 29, 4194\u20134204 (2010).","journal-title":"Oncogene"},{"key":"4600_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2013.08.030","volume":"342","author":"B Zhao","year":"2014","unstructured":"Zhao, B. et al. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer Lett. 342, 43\u201351 (2014).","journal-title":"Cancer Lett."},{"key":"4600_CR16","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1159\/000447823","volume":"39","author":"W Wei","year":"2016","unstructured":"Wei, W. et al. MiR-30a-5p suppresses tumor metastasis of human colorectal cancer by targeting ITGB3. Cell. Physiol. Biochem. 39, 1165\u20131176 (2016).","journal-title":"Cell. Physiol. Biochem."},{"key":"4600_CR17","doi-asserted-by":"publisher","first-page":"17905","DOI":"10.18632\/oncotarget.7560","volume":"7","author":"JM Symonds","year":"2016","unstructured":"Symonds, J. M., Ohm, A. M., Tan, A.-C. & Reyland, M. E. PKC\u03b4 regulates integrin \u03b1 V \u03b2 3 expression and transformed growth of K-ras dependent lung cancer cells. Oncotarget 7, 17905\u201317919 (2016).","journal-title":"Oncotarget"},{"key":"4600_CR18","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1128\/MCB.21.9.3192-3205.2001","volume":"21","author":"D Woods","year":"2001","unstructured":"Woods, D. et al. Induction of \u03b23-integrin gene expression by sustained activation of the Ras-regulated Raf\u2013MEK\u2013extracellular signal-regulated kinase signaling pathway. Mol. Cell. Biol. 21, 3192\u20133205 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"4600_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2014.08.044","volume":"355","author":"FH Wu","year":"2014","unstructured":"Wu, F.-H. et al. Cyclin D1b splice variant promotes \u03b1v\u03b23-mediated adhesion and invasive migration of breast cancer cells. Cancer Lett. 355, 159\u2013167 (2014).","journal-title":"Cancer Lett."},{"key":"4600_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/wsbm.10","volume":"1","author":"B Zinshteyn","year":"2009","unstructured":"Zinshteyn, B. & Nishikura, K. Adenosine-to-inosine RNA editing. Wiley Interdiscip. Rev. Syst. Biol. Med. 1, 202\u2013209 (2009).","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"4600_CR21","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1074\/jbc.R200025200","volume":"278","author":"S Maas","year":"2003","unstructured":"Maas, S., Rich, A. & Nishikura, K. A-to-I RNA editing: recent news and residual mysteries. J. Biol. Chem. 278, 1391\u20131394 (2003).","journal-title":"J. Biol. Chem."},{"key":"4600_CR22","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1101\/gr.2855504","volume":"14","author":"DDY Kim","year":"2004","unstructured":"Kim, D. D. Y. et al. Widespread RNA editing of embedded Alu elements in the human transcriptome. Genome Res. 14, 1719\u20131725 (2004).","journal-title":"Genome Res."},{"key":"4600_CR23","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/gb-2006-7-4-r27","volume":"7","author":"MJ Blow","year":"2006","unstructured":"Blow, M. J. et al. RNA editing of human microRNAs. Genome Biol. 7, R27\u2013R27 (2006).","journal-title":"Genome Biol."},{"key":"4600_CR24","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1261\/rna.7350304","volume":"10","author":"DJ Luciano","year":"2004","unstructured":"Luciano, D. J., Mirsky, H., Vendetti, N. J. & Maas, S. RNA editing of a miRNA precursor. RNA 10, 1174\u20131177 (2004).","journal-title":"RNA"},{"key":"4600_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.celrep.2013.10.002","volume":"5","author":"X Wang Isabel","year":"2013","unstructured":"Wang Isabel, X. et al. ADAR regulates RNA editing, transcript stability, and gene expression. Cell Rep. 5, 849\u2013860 (2013).","journal-title":"Cell Rep."},{"key":"4600_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.4161\/rna.7.5.13269","volume":"7","author":"BSE Heale","year":"2010","unstructured":"Heale, B. S. E., Eulalio, A., Schulte, L., Vogel, J. & O\u2019Connell, M. A. Analysis of A to I editing of miRNA in macrophages exposed to salmonella. RNA Biol. 7, 621\u2013627 (2010).","journal-title":"RNA Biol."},{"key":"4600_CR27","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1172\/JCI62980","volume":"123","author":"Y Nemlich","year":"2013","unstructured":"Nemlich, Y. et al. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J. Clin. Invest. 123, 2703\u20132718 (2013).","journal-title":"J. Clin. Invest."},{"key":"4600_CR28","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cell.2013.03.024","volume":"153","author":"H Ota","year":"2013","unstructured":"Ota, H. et al. ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell 153, 575\u2013589 (2013).","journal-title":"Cell"},{"key":"4600_CR29","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1128\/MCB.25.16.6956-6963.2005","volume":"25","author":"Y Nie","year":"2005","unstructured":"Nie, Y., Ding, L., Kao, P. N., Braun, R. & Yang, J.-H. ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing. Mol. Cell. Biol. 25, 6956\u20136963 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"4600_CR30","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jmb.2009.08.070","volume":"393","author":"Y Wang","year":"2009","unstructured":"Wang, Y. & Samuel, C. E. Adenosine deaminase ADAR1 increases gene expression at the translational level by decreasing protein kinase PKR-dependent eIF-2[alpha] phosphorylation. J. Mol. Biol. 393, 777\u2013787 (2009).","journal-title":"J. Mol. Biol."},{"key":"4600_CR31","doi-asserted-by":"publisher","first-page":"10119","DOI":"10.1128\/JVI.02457-08","volume":"83","author":"G Clerzius","year":"2009","unstructured":"Clerzius, G. et al. ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication. J. Virol. 83, 10119\u201310128 (2009).","journal-title":"J. Virol."},{"key":"4600_CR32","doi-asserted-by":"publisher","first-page":"28999","DOI":"10.18632\/oncotarget.4905","volume":"6","author":"G Galore-Haskel","year":"2015","unstructured":"Galore-Haskel, G. et al. A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme. Oncotarget 6, 28999\u201329015 (2015).","journal-title":"Oncotarget"},{"key":"4600_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ncb3110","volume":"17","author":"E Shoshan","year":"2015","unstructured":"Shoshan, E. et al. Hypo adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat. Cell Biol. 17, 311\u2013321 (2015).","journal-title":"Nat. Cell Biol."},{"key":"4600_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/nar\/gkg034","volume":"31","author":"C von Mering","year":"2003","unstructured":"von Mering, C. et al. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 31, 258\u2013261 (2003).","journal-title":"Nucleic Acids Res."},{"key":"4600_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-14-1","volume":"14","author":"L Sun","year":"2015","unstructured":"Sun, L. et al. MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3. Mol. Cancer 14, 1\u201313 (2015).","journal-title":"Mol. Cancer"},{"key":"4600_CR36","doi-asserted-by":"crossref","first-page":"43712","DOI":"10.18632\/oncotarget.6227","volume":"22","author":"SY Yang","year":"2015","unstructured":"Yang, S. Y. et al. miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47. Oncotarget 22, 43712\u201343730 (2015).","journal-title":"Oncotarget"},{"key":"4600_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are MicroRNA targets. Cell 120, 15\u201320 (2005).","journal-title":"Cell"},{"key":"4600_CR38","doi-asserted-by":"publisher","first-page":"6761","DOI":"10.1007\/s13277-015-4575-8","volume":"37","author":"H Chen","year":"2016","unstructured":"Chen, H. et al. miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1. Tumor Biol. 37, 6761\u20136768 (2016).","journal-title":"Tumor Biol."},{"key":"4600_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13046-016-0348-5","volume":"35","author":"B Jiang","year":"2016","unstructured":"Jiang, B. et al. MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2. J. Exp. Clin. Cancer Res. 35, 69 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"4600_CR40","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.molcel.2010.11.020","volume":"40","author":"C Levy","year":"2010","unstructured":"Levy, C. et al. Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol. Cell 40, 841\u2013849 (2010).","journal-title":"Mol. Cell"},{"key":"4600_CR41","first-page":"11854","volume":"8","author":"S Li","year":"2015","unstructured":"Li, S. et al. miR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells. Int. J. Clin. Exp. Pathol. 8, 11854\u201311862 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"4600_CR42","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/j.ajpath.2014.05.004","volume":"184","author":"XV Qadir","year":"2014","unstructured":"Qadir, X. V., Han, C., Lu, D., Zhang, J. & Wu, T. miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1\/PTEN\/Akt pathway. Am. J. Pathol. 184, 2355\u20132364 (2014).","journal-title":"Am. J. Pathol."},{"key":"4600_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.archoralbio.2016.02.013","volume":"66","author":"K Qiu","year":"2016","unstructured":"Qiu, K., Huang, Z., Huang, Z., He, Z. & You, S. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma. Arch. Oral Biol. 66, 92\u201397 (2016).","journal-title":"Arch. Oral Biol."},{"key":"4600_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/bjc.2011.568","volume":"106","author":"Y Xu","year":"2012","unstructured":"Xu, Y., Brenn, T., Brown, E. R. S., Doherty, V. & Melton, D. W. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br. J. Cancer 106, 553\u2013561 (2012).","journal-title":"Br. J. Cancer"},{"key":"4600_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biopha.2015.12.018","volume":"77","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin. Biomed. Pharmacother. 77, 135\u2013141 (2016).","journal-title":"Biomed. Pharmacother."},{"key":"4600_CR46","doi-asserted-by":"publisher","first-page":"e18936","DOI":"10.1371\/journal.pone.0018936","volume":"6","author":"E Greenberg","year":"2011","unstructured":"Greenberg, E. et al. Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS ONE 6, e18936 (2011).","journal-title":"PLoS ONE"},{"key":"4600_CR47","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1038\/ncomms11452","volume":"7","author":"X Jiang","year":"2016","unstructured":"Jiang, X. et al. miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia. Nat. Commun. 7, 11452 (2016).","journal-title":"Nat. Commun."},{"key":"4600_CR48","first-page":"14013","volume":"8","author":"CY Wang","year":"2015","unstructured":"Wang, C.-Y. et al. MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4. Int. J. Clin. Exp. Pathol. 8, 14013\u201314020 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"4600_CR49","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1101\/gr.2722704","volume":"14","author":"A Rodriguez","year":"2004","unstructured":"Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L. & Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 14, 1902\u20131910 (2004).","journal-title":"Genome Res."},{"key":"4600_CR50","doi-asserted-by":"publisher","first-page":"e5279","DOI":"10.1371\/journal.pone.0005279","volume":"4","author":"DL Corcoran","year":"2009","unstructured":"Corcoran, D. L. et al. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS ONE 4, e5279 (2009).","journal-title":"PLoS ONE"},{"key":"4600_CR51","doi-asserted-by":"publisher","first-page":"e11176","DOI":"10.1371\/journal.pone.0011176","volume":"5","author":"G Markel","year":"2010","unstructured":"Markel, G. et al. The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis. PLoS ONE 5, e11176 (2010).","journal-title":"PLoS ONE"},{"key":"4600_CR52","doi-asserted-by":"publisher","first-page":"36202","DOI":"10.1074\/jbc.M113.498634","volume":"288","author":"J Long","year":"2013","unstructured":"Long, J. et al. MicroRNA-22 is a master regulator of bone morphogenetic protein-7\/6 homeostasis in the kidney. J. Biol. Chem. 288, 36202\u201336214 (2013).","journal-title":"J. Biol. Chem."},{"key":"4600_CR53","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1158\/0008-5472.CAN-13-3555","volume":"74","author":"LM Kong","year":"2014","unstructured":"Kong, L.-M. et al. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis. Cancer Res. 74, 3764\u20133778 (2014).","journal-title":"Cancer Res."},{"key":"4600_CR54","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1101\/gad.1706508","volume":"22","author":"F Ozsolak","year":"2008","unstructured":"Ozsolak, F. et al. Chromatin structure analyses identify miRNA promoters. Genes Dev. 22, 3172\u20133183 (2008).","journal-title":"Genes Dev."},{"key":"4600_CR55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ni.1680","volume":"10","author":"JC Hartner","year":"2009","unstructured":"Hartner, J. C., Walkley, C. R., Lu, J. & Orkin, S. H. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat. Immunol. 10, 109\u2013115 (2009).","journal-title":"Nat. Immunol."},{"key":"4600_CR56","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.immuni.2015.11.001","volume":"43","author":"K Pestal","year":"2015","unstructured":"Pestal, K. et al. Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development. Immunity 43, 933\u2013944 (2015).","journal-title":"Immunity"},{"key":"4600_CR57","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1126\/science.aac7049","volume":"349","author":"BJ Liddicoat","year":"2015","unstructured":"Liddicoat, B. J. et al. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349, 1115\u20131120 (2015).","journal-title":"Science"},{"key":"4600_CR58","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/nsmb.3403","volume":"24","author":"M Sakurai","year":"2017","unstructured":"Sakurai, M. et al. ADAR1 controls apoptosis of stressed cells by inhibiting Staufen1-mediated mRNA decay. Nat. Struct. Mol. Biol. 24, 534\u2013543 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"4600_CR59","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3892\/or.2015.4333","volume":"35","author":"S Zhang","year":"2016","unstructured":"Zhang, S. et al. MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma. Oncol. Rep. 35, 559\u2013567 (2016).","journal-title":"Oncol. Rep."},{"key":"4600_CR60","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4161\/rna.23343","volume":"10","author":"T Shimokawa","year":"2013","unstructured":"Shimokawa, T. et al. RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling. RNA Biol. 10, 321\u2013333 (2013).","journal-title":"RNA Biol."},{"key":"4600_CR61","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1038\/ncomms4197","volume":"5","author":"M Koga","year":"2014","unstructured":"Koga, M. et al. Foxd1 is a mediator and indicator of the cell reprogramming process. Nat. Commun. 5, 3197 (2014).","journal-title":"Nat. Commun."},{"key":"4600_CR62","doi-asserted-by":"publisher","first-page":"7989","DOI":"10.1038\/sj.onc.1206766","volume":"22","author":"A Muratovska","year":"2003","unstructured":"Muratovska, A., Zhou, C., He, S., Goodyer, P. & Eccles, M. R. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22, 7989\u20137997 (2003).","journal-title":"Oncogene"},{"key":"4600_CR63","first-page":"6","volume":"3","author":"CG Li","year":"2012","unstructured":"Li, C. G. & Eccles, M. R. PAX genes in cancer; friends or foes? Front. Genet. 3, 6 (2012).","journal-title":"Front. Genet."},{"key":"4600_CR64","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/pcmr.12308","volume":"27","author":"F Cavodeassi","year":"2014","unstructured":"Cavodeassi, F. & Bovolenta, P. New functions for old genes: Pax6 and Mitf in eye pigment biogenesis. Pigment Cell Melanoma Res. 27, 1005\u20131007 (2014).","journal-title":"Pigment. Cell Melanoma Res."},{"key":"4600_CR65","doi-asserted-by":"publisher","first-page":"e1004360","DOI":"10.1371\/journal.pgen.1004360","volume":"10","author":"S Raviv","year":"2014","unstructured":"Raviv, S. et al. PAX6 regulates melanogenesis in the retinal pigmented epithelium through feed-forward regulatory interactions with MITF. PLoS Genet. 10, e1004360 (2014).","journal-title":"PLoS Genet."},{"key":"4600_CR66","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1093\/nar\/gkt996","volume":"42","author":"G Ramaswami","year":"2014","unstructured":"Ramaswami, G. & Li, J. B. RADAR: a rigorously annotated database of A-to-I RNA editing. Nucleic Acids Res. 42, D109\u2013D113 (2014).","journal-title":"Nucleic Acids Res."},{"key":"4600_CR67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm.2015.4","volume":"17","author":"K Nishikura","year":"2016","unstructured":"Nishikura, K. A-to-I editing of coding and non-coding RNAs by ADARs. Nat. Rev. Mol. Cell Biol. 17, 83\u201396 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"4600_CR68","doi-asserted-by":"publisher","first-page":"D140","DOI":"10.1093\/nar\/gkj112","volume":"34","author":"S Griffiths-Jones","year":"2006","unstructured":"Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A. & Enright, A. J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34, D140\u2013D144 (2006).","journal-title":"Nucleic Acids Res."},{"key":"4600_CR69","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2105-13-134","volume":"13","author":"J Ye","year":"2012","unstructured":"Ye, J. et al. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13, 134\u2013134 (2012).","journal-title":"BMC Bioinformatics"},{"key":"4600_CR70","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10585-005-1262-y","volume":"22","author":"N Ahmed","year":"2005","unstructured":"Ahmed, N., Riley, C., Rice, G. & Quinn, M. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin. Exp. Metastasis 22, 391\u2013402 (2005).","journal-title":"Clin. Exp. Metastasis"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04600-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04600-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04600-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T14:11:57Z","timestamp":1671545517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-04600-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["4600"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-04600-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,31]]},"assertion":[{"value":"7 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2154"}}